@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAStQPgbP41zxdjFfVDaSgKPNS3NsFMJq63AVX_wT8Fc8> .
@prefix sub: <http://purl.org/np/RAStQPgbP41zxdjFfVDaSgKPNS3NsFMJq63AVX_wT8Fc8#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix ns1: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo .
}

sub:assertion {
  sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  
  sub:version prov:value "1"^^xsd:integer .
  
  rdf:object ns2:C0013227 "drugs";
    ns2:C0332281 "associated";
    ns2:C1273517 "used";
    ns2:C1517586 "experimental";
    ns2:C3687832 "drugs";
    ns2:C3828767 "November";
    ns2:C5203670 "coronavirus disease 2019" .
  
  rdf:predicate ns1:TRIPLE_UID:p5hau30l-TRIPLE-ABSTRACT-1 "identify" .
  
  rdf:subject ns2:C0011777 "dexamethasone";
    ns2:C0015980 "interferon beta";
    ns2:C0020336 "hydroxychloroquine";
    ns2:C0035525 "ribavirin";
    ns2:C0052796 "azithromycin";
    ns2:C0245109 "anakinra";
    ns2:C0751599 "interferon beta";
    ns2:C0812732 "azithromycin";
    ns2:C0939237 "lopinavir / ritonavir";
    ns2:C1138226 "favipiravir";
    ns2:C1145759 "atazanavir";
    ns2:C1609165 "tocilizumab";
    ns2:C2825876 "interferon beta";
    ns2:C3885145 "sarilumab";
    ns2:C4019073 "interferon beta";
    ns2:C4726677 "Remdesivir" .
  
  rdfs:Triple-UID ns3:TRIPLE_UID:p5hau30l-TRIPLE-ABSTRACT-1 "p5hau30l-TRIPLE-ABSTRACT-1" .
  
  rdfs:sentence rdfs:label "Remdesivir, dexamethasone, azithromycin, favipiravir, lopinavir/ritonavir, atazanavir, hydroxychloroquine, interferon beta, ribavirin, tocilizumab, anakinra and sarilumab were identified as experimental drugs being used in the associated coronavirus disease 2019 (COVID)-19) trials as of November 2020." .
  
  rdfs:triple rdfs:label "Remdesivir , dexamethasone , azithromycin , favipiravir , lopinavir / ritonavir , atazanavir , hydroxychloroquine , interferon beta , ribavirin , tocilizumab , anakinra and sarilumab identified as experimental drugs being used in the associated coronavirus disease 2019 ( COVID)-19 ) trials as of November 2020" .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-07-25T21:46:13.433076"^^xsd:dateTime .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "M9PlKN1mfAR12IM+675MrQBjS4TRtRIDA6dlFhoYOxIo98+SXa85g8A+VlYF3BAxO4NorpojCmhXCHBoKmFN874bmKnpZlRuIq4KZAMLfXJhGFLmqbOTQa/wTnz3joMBVChZ0/UyQEFAgMSw2Ls6sBEI2S7NzGs0ziL+p6ertRw=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-07-25T21:46:13.433076"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}